Learn about a novel automated workflow using the spheroONE and Pu.Ma System EC (Protein Fluidics) for drug response profiling of patient-derived tumor models. Primary tumoroids are sorted & dispensed into flowchips for drug testing using phenotypic assays. Automated compound incubation and viability staining lead to consistent reproducible high-quality data.
Watch it now on our partner’s website: https://proteinfluidics.com/webinar-may-29-2024-register/
About Protein Fluidics: Protein Fluidics develops and commercializes automated assay platforms based on proprietary microfluidic technologies. Their solutions are designed to streamline experimental workflows and support data-driven decision-making in life-science research. With a strong focus on enabling scientific innovation, Protein Fluidics provides advanced automation tools used in areas such as oncology, diagnostics, and related applications. The company is based in the San Francisco Bay Area and is privately held, backed by multiple rounds of strategic investment.